Cargando…
Complement Activation by Adeno-Associated Virus-Neutralizing Antibody Complexes
Treatment of monogenetic disorders using vectors based on adeno-associated virus (AAV) is an area of intense interest. AAV is non-pathogenic human virus, and preexisting capsid antibodies are prevalent in the population posing a challenge to the safety and efficacy of AAV-mediated gene therapies. In...
Autores principales: | West, Cara, Federspiel, Joel D., Rogers, Kara, Khatri, Arpana, Rao-Dayton, Sheila, Ocana, Mireia Fernandez, Lim, Sean, D'Antona, Aaron Michael, Casinghino, Sandra, Somanathan, Suryanarayan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mary Ann Liebert, Inc., publishers
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10282828/ https://www.ncbi.nlm.nih.gov/pubmed/37082966 http://dx.doi.org/10.1089/hum.2023.018 |
Ejemplares similares
-
Higher Seroprevalence of Anti-Adeno-Associated Viral Vector Neutralizing Antibodies Among Racial Minorities in the United States
por: Khatri, Arpana, et al.
Publicado: (2022) -
Adeno-associated virus receptor complexes and implications for adeno-associated virus immune neutralization
por: Large, Edward E., et al.
Publicado: (2023) -
International Workshop on Evolutionary Links in the Zoo of Interacting Binaries
por: D'Antona, F
Publicado: (1993) -
Three-Dimensional Visualization of Transcription Sites and Their Association with Splicing Factor–Rich Nuclear Speckles
por: Wei, Xiangyun, et al.
Publicado: (1999) -
Digital signal processing for measurement systems: theory and applications
por: D'Antona, Gabriele, et al.
Publicado: (2006)